Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
52.99 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -184.678 | -181.119 | -69.612 | -133.996 | -140.729 | -74.064 | -33.709 | -25.872 | -11.073 | -6.493 | -21.431 | -18.13 |
| Depreciation & Amortization
| 1.758 | 1.672 | 1.158 | 0.69 | 0.834 | 0.442 | 0.223 | 0.144 | 0 | 0 | 0.02 | 0.017 |
| Deferred Income Tax
| -0.423 | 0 | -100 | 0 | 0 | 0 | 1.863 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 32.553 | 19.831 | 20.804 | 17.455 | 11.875 | 6.39 | 2.278 | 1.168 | 0.298 | 0.066 | 0.127 | 0 |
| Change In Working Capital
| 4.807 | -19.724 | 1.897 | -5.895 | 5.067 | 0.667 | -0.039 | 1.33 | 2.375 | -0.801 | 2 | 0.201 |
| Accounts Receivables
| -8.643 | -5.199 | -1.25 | 0 | 0 | 0 | 0 | 0 | -0.06 | 0 | 0 | 0 |
| Inventory
| -5.707 | -2.806 | -0.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 14.773 | 1.543 | 18.312 | 10.507 | 10.507 | 6.953 | 1.946 | 0.467 | 3.838 | 0 | -0.78 | 1.576 |
| Other Working Capital
| 4.384 | -13.262 | -15.154 | -16.402 | -5.44 | -6.286 | -1.985 | 0.863 | -1.463 | -0.801 | 2.78 | -1.375 |
| Other Non Cash Items
| 9.826 | 5.912 | -0.25 | -0.234 | 0.203 | 4.509 | -0.076 | 0.011 | 1.423 | -0.28 | 0.255 | 0.082 |
| Operating Cash Flow
| -136.157 | -173.428 | -146.003 | -121.98 | -122.75 | -62.056 | -29.46 | -23.219 | -6.977 | -7.508 | -19.156 | -17.83 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.047 | -4.281 | -5.434 | -0.214 | -3.385 | -0.722 | -0.133 | -1.057 | -0.017 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 4 | 100 | -158.745 | 24.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -354.918 | -251.937 | -524.972 | -86.869 | -295.825 | -248.592 | -126.917 | -15.222 | 0 | 0 | -28.741 | -8.799 |
| Sales Maturities Of Investments
| 354.967 | 284.247 | 361.247 | 245.614 | 271.24 | 162.166 | 17.006 | 11.169 | 0 | 0 | 23.613 | 3.529 |
| Other Investing Activites
| -5.667 | -4 | 7 | 158.745 | -24.585 | -86.426 | -109.911 | -4.053 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -5.665 | 28.029 | -62.159 | 158.531 | -27.97 | -87.148 | -110.044 | -5.11 | -0.017 | 0 | -5.128 | -5.27 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -7.398 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 48.875 | 131.112 | 166.481 | 161.352 | 161.352 | 164.686 | 125.658 | 0 | 39.617 | 0 | 0 | 0.043 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 32.891 | 82.716 | 166.481 | -159.343 | 2.122 | 164.686 | 41.542 | 0 | 41.711 | 7.419 | 19.882 | 22.397 |
| Financing Cash Flow
| 74.368 | 213.828 | 166.481 | 2.009 | 163.474 | 164.686 | 167.2 | 0 | 41.711 | 7.419 | 19.882 | 22.44 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.142 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -67.596 | 68.429 | -41.681 | 38.56 | 12.754 | 15.482 | 27.696 | -28.329 | 34.717 | -0.089 | -4.402 | -0.66 |
| Cash At End Of Period
| 60.409 | 128.005 | 59.576 | 101.257 | 62.697 | 49.943 | 34.236 | 6.54 | 34.869 | 0.152 | 7.364 | 11.766 |